Antibiotic resistance Study Guide

📖 Core Concepts Antimicrobial Resistance (AMR) – When a microbe (bacteria, virus, fungus, parasite) survives a drug that would normally kill or inhibit it. The resistance trait belongs to the microbe, not the patient. One Health – The health of people, animals, and the environment are linked; AMR control requires coordinated actions across all three sectors. Stewardship – Organized programs (hospital‑level, primary‑care, national) that promote the right drug, dose, route, and duration to preserve drug efficacy. Horizontal Gene Transfer (HGT) – Movement of resistance genes between bacteria via conjugation (plasmid exchange), transformation (uptake of free DNA), or transduction (phage‑mediated). AWaRe Classification – WHO framework: Access (first‑line, narrow‑spectrum), Watch (higher resistance risk), Reserve (last‑resort). Guides prescribing in stewardship programs. 📌 Must Remember Global deaths 2019: 1.27 M directly from AMR; 5 M associated deaths (incl. 20 % of under‑5 deaths). Economic burden: up to US $1 trillion/yr by 2050; $1–3.4 trillion annually by 2030. Key “superbugs”: E. coli, S. aureus, K. pneumoniae, S. pneumoniae, A. baumannii, P. aeruginosa. Antibiotic misuse: 1/3 of outpatient prescriptions unnecessary; 30‑60 % of inpatient prescriptions unnecessary. Agriculture: 80 % of U.S. antibiotic use is in animals; 70 % of that involves medically important drugs. Stewardship impact: Shortens hospital stay ≈ 1 day, no mortality increase. Five Rights of prescribing: Right patient, drug, dose, route, time. 🔄 Key Processes Development of Bacterial Resistance Spontaneous mutation during replication → altered target or metabolic pathway. HGT → acquisition of plasmids/ transposons carrying resistance genes. Selection pressure (over‑use, sub‑therapeutic dosing) enriches resistant clones. Antimicrobial Stewardship Workflow (hospital example) Assessment → Identify infection type, severity, pathogen risk. Selection → Choose narrow‑spectrum (Access) drug per AWaRe. Dosing → Weight/renal‑function‑adjusted dose. Duration → Evidence‑based length; early clinical improvement usually permits stopping without raising resistance. Review → 48‑h de‑escalation based on culture/diagnostic results. One Health Surveillance Loop Collect antimicrobial use & resistance data → humans, animals, environment → integrated database → risk assessment → policy adjustment → feedback to prescribers/farmers. 🔍 Key Comparisons Antibiotic vs Antiviral Resistance Antibiotic: Enzyme inactivation (β‑lactamases), target modification, efflux pumps. Antiviral: Mutations in viral target proteins (e.g., neuraminidase) that reduce drug binding. Watch vs Reserve antibiotics (AWaRe) Watch: Higher resistance potential, used for specific severe infections; aim to limit use. Reserve: Last‑line agents (e.g., colistin, carbapenems) kept for proven multidrug‑resistant infections only. Continuous Monotherapy vs Alternating Therapy Monotherapy: Simpler but can select for single‑drug resistance. Alternating: Rotates 2‑3 classes; in vitro reduces resistance emergence but clinical benefit is mixed. ⚠️ Common Misunderstandings “Finishing the course” always needed – For many infections, stopping early after clinical improvement does not increase resistance; overly long courses drive resistance. Resistance is the patient’s fault – Resistance is a property of the microbe; patient behavior (e.g., sharing meds) can propagate resistant strains but does not cause the genetic change. All antibiotics are the same – Spectrum, pharmacodynamics, and resistance risk differ dramatically; misuse of broad‑spectrum agents accelerates AMR. 🧠 Mental Models / Intuition “Evolutionary pressure cooker” – Think of a crowded kitchen where only the toughest chefs (resistant bacteria) survive when the heat (antibiotic) is turned up; removing the heat early still leaves the toughest alive. “Gene traffic jam” – Horizontal gene transfer is like cars (plasmids) moving between lanes (bacterial cells) on a highway; the more congested the road (high antibiotic use), the more likely a resistant “vehicle” will be shared. 🚩 Exceptions & Edge Cases Environmental reservoirs – Waste‑water treatment plants often fail to remove resistant bacteria; resistance can persist even when clinical use is curtailed. Rapid diagnostics – Provide results within an 8‑hour shift; however, some point‑of‑care tests (e.g., malaria RDTs) may inadvertently increase antibiotic prescribing if clinicians interpret a negative result as “needs antibiotics.” Collateral sensitivity – Resistance to drug A can increase susceptibility to drug B, but this pattern is not universal; must be confirmed for each organism‑drug pair. 📍 When to Use Which Choose Access (AWaRe) antibiotic for common, uncomplicated infections (e.g., community‑acquired pneumonia, uncomplicated UTIs). Escalate to Watch only when pathogen risk or severity warrants broader coverage (e.g., hospital‑acquired pneumonia). Reserve agents only after susceptibility testing confirms no effective Access/Watch options (e.g., carbapenem‑resistant Enterobacteriaceae). Apply stewardship tools (decision‑support alerts, written patient info) for upper‑respiratory infections where viral etiology is likely. Implement WASH improvements in settings with high diarrheal disease burden to reduce overall antibiotic demand. 👀 Patterns to Recognize Repeated prescription of the same broad‑spectrum drug → red flag for stewardship audit. Clusters of multidrug‑resistant infections after COVID‑19 surges → look for increased empirical antibiotic use. High proportion of “Watch” prescriptions in a facility → indicates need for prescriber education and AWaRe enforcement. Environmental sampling showing identical resistance genes in hospital effluent and community water → suggests wastewater contamination pathway. 🗂️ Exam Traps Distractor: “Stopping antibiotics early always causes resistance.” – Wrong; early stopping is usually safe for many infections and reduces pressure. Distractor: “Only bacteria develop resistance.” – Incorrect; viruses, fungi, and parasites also develop resistance (antiviral, antifungal, antiparasitic). Distractor: “All antimicrobial use in agriculture is illegal worldwide.” – False; many countries still allow medically important antibiotics for growth promotion, though restrictions are increasing. Distractor: “Horizontal gene transfer occurs only via plasmids.” – Misleading; also via transformation (free DNA) and transduction (phages). Distractor: “Vaccines drive resistance just like antibiotics.” – Wrong; vaccines target multiple antigens and generally prevent resistance development.